Surgery Partners, Inc. (SGRY)
NASDAQ: SGRY · Real-Time Price · USD
13.36
-0.29 (-2.12%)
May 29, 2026, 4:00 PM EDT - Market closed
Surgery Partners Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,648 | - | - | - | 2,539 | 2,225 | |
Revenue Growth (YoY) | 7.52% | - | - | - | 14.12% | 19.62% |
Cost of Revenue | 2,580 | 2,544 | 2,369 | 2,096 | 1,964 | 1,734 |
Gross Profit | -932.6 | -2,544 | -2,369 | -2,096 | 574.9 | 491.4 |
Selling, General & Admin | 2,265 | 2,461 | 2,306 | 2,041 | 1,910 | 1,705 |
Depreciation & Amortization Expenses | 178.2 | 176 | 152.6 | 118.1 | 114.8 | 98.8 |
Other Operating Expenses | 290.7 | 282.6 | 301 | 247.6 | 174.9 | 172.2 |
Total Operating Expenses | 2,734 | 2,919 | 2,759 | 2,407 | 2,200 | 1,976 |
Operating Income | 393.4 | 389.5 | 348.8 | 328 | 345.2 | 302.2 |
Interest Income | 21.4 | 22.9 | 19.5 | 14.2 | 12.5 | 11.3 |
Interest Expense | -279.5 | -272.6 | -201.7 | -193 | -234.9 | -221 |
Other Non-Operating Income (Expense) | -42.3 | -45.9 | -45.2 | -36.6 | -19.5 | 30.8 |
Total Non-Operating Income (Expense) | -300.4 | -295.6 | -227.4 | -215.4 | -241.9 | -178.9 |
Pretax Income | 113.9 | 116.9 | 147.1 | 135 | 110.3 | 81.2 |
Provision for Income Taxes | -16.8 | -18 | -134.6 | 0.3 | -23.3 | -10.5 |
Net Income | -76.1 | -77.9 | -168.1 | -11.9 | -54.6 | -152.1 |
Minority Interest in Earnings | -173.2 | -176.8 | -180.6 | -147.2 | -141.6 | -141.6 |
Net Income Attributable to Preferred Dividends | - | - | - | - | - | -10.3 |
Net Income to Common | -76.1 | -77.9 | -168.1 | -11.9 | -54.6 | -152.1 |
Shares Outstanding (Basic) | 128 | 127 | 126 | 126 | 92 | 72 |
Shares Outstanding (Diluted) | 128 | 127 | 126 | 126 | 92 | 72 |
Shares Change (YoY) | 1.08% | 0.86% | 0.40% | 36.61% | 26.96% | 48.49% |
EPS (Basic) | -0.60 | -0.61 | -1.33 | -0.09 | -0.59 | -1.12 |
EPS (Diluted) | -0.60 | -0.61 | -1.33 | -0.09 | -0.59 | -1.12 |
Shares Outstanding | 130.8 | 129.32 | 127.11 | 126.59 | 125.96 | 89.33 |
Free Cash Flow | 208 | 195.6 | 209.7 | 205 | 78.2 | 29.5 |
Free Cash Flow Growth | 6.34% | -6.72% | 2.29% | 162.15% | 165.08% | -85.54% |
Free Cash Flow Per Share | 1.63 | 1.54 | 1.66 | 1.63 | 0.85 | 0.41 |
Gross Margin | -56.60% | - | - | - | 22.64% | 22.08% |
Operating Margin | 23.88% | - | - | - | 13.59% | 13.58% |
Profit Margin | 7.93% | - | - | - | 5.26% | 4.12% |
FCF Margin | 12.62% | - | - | - | 3.08% | 1.33% |
EBITDA | 571.6 | 565.5 | 501.4 | 446.1 | 460 | 401 |
EBITDA Margin | 34.69% | - | - | - | 18.12% | 18.02% |
EBIT | 393.4 | 389.5 | 348.8 | 328 | 345.2 | 302.2 |
EBIT Margin | 23.88% | - | - | - | 13.59% | 13.58% |
Effective Tax Rate | -14.75% | -15.40% | -91.50% | 0.22% | -21.12% | -12.93% |